Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00184015
Brief Title: Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)

First Submitted : September 12, 2005
First Submitted that Met QC Criteria : September 12, 2005
First Posted : September 16, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : April 8, 2017
Last Update Posted : April 11, 2017